Bio Impact Capital LLC Guardant Health, Inc. Transaction History
Bio Impact Capital LLC
- $669 Million
- Q4 2024
A detailed history of Bio Impact Capital LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 452,739 shares of GH stock, worth $19.4 Million. This represents 2.07% of its overall portfolio holdings.
Number of Shares
452,739
Previous 499,170
9.3%
Holding current value
$19.4 Million
Previous $11.4 Million
20.85%
% of portfolio
2.07%
Previous 1.79%
Shares
3 transactions
Others Institutions Holding GH
# of Institutions
347Shares Held
120MCall Options Held
793KPut Options Held
1.85M-
Vanguard Group Inc Valley Forge, PA12.1MShares$517 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$482 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.42MShares$275 Million8.64% of portfolio
-
Baillie Gifford & CO5.45MShares$234 Million0.13% of portfolio
-
Cadian Capital Management, LP New York, NY5.22MShares$224 Million9.25% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.38B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...